Business Wire - Corixa and GlaxoSmithKline Respond to FDA; Complete Review Letter for BEXXAR
December 11th, 2008 Business Editors & Health/Medical Writers
BIOWIRE2K
SEATTLE & PHILADELPHIA–(BW HealthWire)–March 25, 2002
Corixa Corporation (Nasdaq:CRXA) and GlaxoSmithKline (NYSE:GSK), today announced that Corixa has notified th…
FDA Requests Boxed Warnings on Older Class of Antipsychotic Drugs
December 10th, 2008ROCKVILLE, Md., June 16, 2008–The U.S. Food and Drug
Administration today exercised its new authority under the Food and
Drug Administration Amendments Act of 2007 (FDAAA) to require
manufacturers of “conventional” antipsychotic drugs to make
safety-related changes to prescribing information, or labeling, to
warn about an increased risk of death associated with the off-label
…
OB/GYN News - Atypical antipsychotics
December 5th, 2008The reproductive safety of the older typical antipsychotics, such as haloperidol, is supported by extensive data that have accumulated over the past 40 years, at least with respect to teratogenic risk. Much of the data come from their use in treating nausea, particularly with prochlorperazine (Compazine). While…
Business Wire - Coulter Pharmaceutical And SmithKline Beecham Combine Bexxar With CVP Chemotherapy in a New First-Line Clinical Trial
November 30th, 2008 Business Editors & Health/Medical Writers
SOUTH SAN FRANCISCO, Calif./PHILADELPHIA–(BW HealthWire)–April 26, 2000
Coulter Pharmaceutical (Nasdaq:CLTR) and SmithKline Beecham (NYSE:SBH) today announced a Phase II multicenter investigational trial of Bexxar(TM) …
Preparation for - Tummy Tuck / Abdominoplasty, Body Lift, or Thigh Lift
November 27th, 2008How Should I Prepare for Tummy Tuck or Body Lift Surgery?
Prior to Surgery
The surgeon will provide very specific instructions prior to surgery so you will have an optimal and safe experience. These include- what medications to avoid to prevent excessive bleeding and bruising, required medical exams, what to eat and drink prior to surgery, and the prescription of an anti-nausea pill…
Information for Healthcare Professionals: Antipsychotics
November 21st, 2008ROCKVILLE, Md., June 16, 2008-FDA ALERT
[6/16/2008]: FDA is notifying healthcare professionals that
both conventional and atypical antipsychotics are associated with
an increased risk of mortality in elderly patients treated for
dementia-rel…
Business Wire - Coulter Pharmaceutical and SmithKline Beecham Expand Proprietary Position With Second U.S. Patent Grant This Year
November 14th, 2008 Business Editors, Health/Medical Writers
SOUTH SAN FRANCISCO, Calif. & PHILADELPHIA–(BW HealthWire)–July 26, 2000
Coulter Pharmaceutical (Nasdaq:CLTR) and SmithKline Beecham (NYSE:SBH) today announced that the U.S. Patent and Trademark Office has issued another patent relating to CD20 antibody therapy for the treatment of lymphoma.
The newest patent, number …
Get Rid of Migraines
November 9th, 2008Migraine is a type of headache and a recognised medical condition. Migraine is widespread in the population. In the U.S., 18% of women and 6% of men report having had at least one migraine episode in the previous year. Migraines afflict about 30 million people in the United States. They may occur at any age, but usually begin between the ages of 10 and 40 and diminish after age 50. Some people experience several mig…
Shake Off the Shakes
November 4th, 2008You don’t have to be Michael Jackson to experience tremors or shaking hands. Most people have them at one time or another and their causes are as varied as the moves Jackson can make.
If your hands tremble, it could be the result of fatigue or tension. Mine usually does after long hours of writing. Others get the shakes after ironing clothes or doing heavy manual labo…
Business Wire - Coulter Pharmaceutical and SmithKline Beecham Announce the Submission of a Biologics License Application for Bexxar to FDA
October 31st, 2008 Business Editors/Health Writers
SOUTH SAN FRANCISCO, Calif. & PHILADELPHIA–(BW HealthWire)–Sept. 18, 2000
Coulter Pharmaceutical, Inc. (Nasdaq:CLTR) and SmithKline Beecham (NYSE:SBH) today announced the re-submission of a Biologics License Application (BLA) to the U.S. Food and Drug Administration (FDA) for Bexxar(TM) (tositumomab, iodine I 131 tositumomab). The companies are see…

